ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

ANAB AnaptysBio Inc

26.58
0.24 (0.91%)
取引時間後
最終更新日: 05:33:53
15分遅延
名称 銘柄コード 市場 種別
AnaptysBio Inc ANAB NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.24 0.91% 26.58 05:33:53
始値 安値 高値 終値 前日終値
26.76 25.64 27.02 26.58 26.34
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2422:00PRNUSActym Therapeutics Appoints Thomas Smart as CEO
2024/3/1205:41EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/1205:36EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/1205:19EDGAR2Form 8-K - Current report
2024/2/2923:15GLOBEAnaptys to Present at TD Cowen’s 44th Annual Health Care..
2024/2/1500:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1422:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/3123:15GLOBEAnaptys to Present at Guggenheim’s 6th Annual Biotechnology..
2024/1/1009:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1009:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0607:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0607:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:09EDGAR2Form 8-K - Current report
2023/11/2806:17EDGAR2Form 8-K - Current report
2023/11/2806:15GLOBEAnaptys Expands Immune Cell Modulator Pipeline with..
2023/11/0806:15GLOBEAnaptys Named a BioSpace 2024 Best Places to Work Winner
2023/11/0305:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0305:18EDGAR2Form 8-K - Current report
2023/11/0305:15GLOBEAnaptys Announces Third Quarter 2023 Financial Results and..
2023/11/0122:15GLOBEAnaptys Announces Participation in November Investor..
2023/10/2605:43EDGAR2Form 8-K - Current report
2023/10/1122:15GLOBEAnaptys to Present Phase 1 Data on ANB032, its BTLA Agonist..
2023/10/1022:01EDGAR2Form 8-K - Current report
2023/10/0921:43DJNAnaptys Sees Positive Trial Results for Imsidolimad..
2023/10/0921:15GLOBEAnaptys to Provide Overview of Rosnilimab, a PD-1 Agonist,..
2023/10/0921:00GLOBEAnaptys Announces Positive Top-Line Phase 3 Clinical Trial..
2023/9/1907:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1907:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1907:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/9/1905:18EDGAR2Form 8-K - Current report
2023/9/1905:15GLOBEAnaptysBio Announces Appointment of John Orwin as Chairman..
2023/9/1222:15GLOBEAnaptysBio to Present at the Stifel 2023 Immunology and..
2023/8/0805:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0805:18EDGAR2Form 8-K - Current report
2023/8/0805:15GLOBEAnaptysBio Announces Second Quarter 2023 Financial..
2023/8/0103:27DJNAnaptysBio Shares Rise 11% After Jemperli Plus Chemotherapy..
2023/8/0102:34GLOBEAnaptysBio- and GSK-Partnered Immuno-Oncology Agent JEMPERLI..
2023/5/3105:15GLOBEAnaptysBio Announces Participation in Upcoming Investor..
2023/5/1205:15GLOBEAnaptysBio Announces First Quarter 2023 Financial Results..

最近閲覧した銘柄

Delayed Upgrade Clock